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Since the reprogramming of adult human terminally differentiated somatic cells into induced pluripotent stem cells (hiPSCs)
became a reality in 2007, only eight years have passed. Yet over this relatively short period, myriad experiments have revolutionized
previous stem cell dogmata.The tremendous promise of hiPSC technology for regenerativemedicine has fuelled rising expectations
from both the public and scientific communities alike. In order to effectively harness hiPSCs to uncover fundamental mechanisms
of disease, it is imperative to first understand the developmental neurobiology underpinning their lineage restriction choices in
order to predictablymanipulate cell fate to desired derivatives. Significant progress in developmental biology provides an invaluable
resource for rationalising directed differentiation of hiPSCs to cellular derivatives of the nervous system. In this paper we begin by
reviewing core developmental concepts underlying neural induction in order to provide context for how such insights have guided
reductionist in vitro models of neural conversion from hiPSCs. We then discuss early factors relevant in neural patterning, again
drawing upon crucial knowledge gained from developmental neurobiological studies. We conclude by discussing open questions
relating to these concepts and how their resolution might serve to strengthen the promise of pluripotent stem cells in regenerative
medicine.
1. The Developmental Origins of the Nervous
System: An Overview
The process of neurodevelopment is spatiotemporally reg-
ulated and necessitates sequential, progressive restrictions
in cell fate. Although some interspecies differences in both
cytoarchitecture and molecular machinery do exist between
mouse and man, rodent models have illuminated key under-
lying mechanisms of lineage restriction to a variety of cell
types. These insights have provided invaluable guidance for
the predictablemanipulation of human pluripotent stem cells
(hPSCs) into myriad cell fates. From the point of fertilisation
of the secondary oocyte, cells commence asymmetric division
and sequentially give rise to the 2-, 4-, and then 8-cell stage
blastomere, which subsequently develops into the blastocyst
(Figure 1). Oct3/4 serves to maintain pluripotency in the
inner cellmass (ICM) of the blastocyst. Although interspecies
differences in cell-type specific factors exist, ultimately and
following implantation and gastrulation, 3 distinct germ
layers emerge: endoderm (which forms the lining of internal
organs), mesoderm (which gives rise to bone, muscle, and
vasculature), and ectoderm (from which results the nervous
system and skin). Figures 1 and 2(a) describe developmen-
tal processes involved in specification of the 3 germ lay-
ers. During gastrulation, this 3-layered structure undergoes
progressive and stereotyped morphological transformations.
The mesoderm and endoderm invaginate inwards and the
ectoderm forms an epithelial sheetwhich ensheathes a central
cavity. The region of the ectoderm surrounding the neural
plate becomes epidermis (Figure 2(a)). An important aspect
of embryogenesis is the assignment of developmental axes.
“Anterior-posterior” can be used to refer to the proximal-
distal axis, which is based on proximity to the future placenta
(in the early blastocyst the proximal pole is represented by
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Figure 1: Developmental stages of mouse embryo. First row (left to right), from the secondary oocyte the blastomere develops (2-cell, 4-
cell, 8-cell, and 16-cell stages) to give rise to the early blastocyst formed of trophectoderm (cells that express Cdx2) and inner cell mass cells
(that express Oct3/4). Later, the inner cell mass gives rise to the epiblast (cells that express Oct3/4 and Nanog) and endoderm (expressing
Oct3/4 and GATA4). Second row (right to left), in the late mouse blastocyst Cdx2 positive cells give rise to the extraembryonic ectoderm and
ectoplacental cone. At the same time the endoderm divides into an embryonic endoderm and an extraembryonic endoderm.The epiblast and
the extraembryonic ectoderm form a cavity lined by embryonic endoderm. From the embryonic endoderm the distal visceral endoderm is
formed (DVE). Third row (left to right), the DVE migrates proximally and will be known as the anterior visceral endoderm (AVE). The final
image (third row, right) shows the development of the primitive streak (mesodermal cells) at the opposite (posterior) pole from the AVE. N.B.
There are 2 different types of endoderm called extraembryonic and embryonic; these differ in their potency and give rise to distinct cellular
derivatives. All timelines are given for mouse and human embryonic development.
the ectoplacental cone as depicted in Figure 1). Later, the
proximal-distal axis will become the future rostrocaudal axis
in vertebrates. However, the term “anterior-posterior axis”
can also sometimes refer to the dorsoventral axis in the adult
state, a distinction that is primarily based on position of the
abdomen (ventral) as opposed to the back/spinal column
(dorsal). Therefore, for ease of reference this review will use
the terms rostrocaudal (“R-C”) and dorsoventral (“D-V”)
axes.
Three principal events characterise early neurodevel-
opment. First, the process of neural induction specifies a
region of the embryonic ectoderm to form the neural plate
(Figure 2(a) [1]). Second, a process termedneurulation occurs
through serial morphological transformations to give rise to
the neural tube (Figure 2(b); [2]). This process consequently
imparts further histological architecture to the developing
neuraxis. Third, the neural tube is divided into functionally
and spatially distinct regions by a programme of inductive
interactions called neural patterning (Figure 2(c) [3]). In
humans, neurulation occurs at 21 days after conception and
depends on a precise sequence of changes in the three-
dimensional shape of individual cells including changes
in cell-cell adhesion. Specific gene expression profiles are
controlled by neuraxial position and local extrinsic mor-
phogenetic instruction. Gastrulation leads to the formation
of the notochord, a distinct cylinder of mesodermal cells
extending along the midline. Ectoderm lies adjacent to the
notochord, from which it receives inductive signals to form
neuroectoderm. Neuroepithelium of the neural plate then
undergoes complex morphogenetic movements involving
cell division, morphological changes, and migration to per-
mit neural tube formation. Following neural tube closure,
the dorsomedial borders of the neural folds become neural
crest derivatives. Cell movements at this stage are critical in
producing different neuraxial regions. For example, in the
ventral midline of the neural tube, cells become a specialized
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Figure 2: Neural induction, neurulation, and neural patterning overview. (a) Neural induction: neuroectoderm (neural plate) differentiation
happens under the influence of theAVE.Themesodermal cells startmigrating in all directions and envelop the embryo between the endoderm
and the ectoderm. At the distal pole of the embryo the node develops, to further act as the “trunk organiser.” (b) Neurulation: from the neural
plate, cells start to proliferate and invaginate in order to form the neural tube and neural crest which derives from the dorsomedial borders
of the neural folds. (c) Neural patterning: cells from the neural tube start to differentiate into precursors for forebrain, midbrain, hindbrain,
and spinal cord according to a rostrocaudal axis. All timelines are given for mouse and human embryonic development.
region called the floor plate (Figure 4(d)). A large variety of
distinct neuronal subtypes are generated during mammalian
neurodevelopment. This diversity is an absolute prerequisite
for the establishment of functional neuronal circuits.
In summary, the consecutive steps of neurodevelopment
include neural induction from embryonic ectoderm, pat-
terning along rostrocaudal (R-C), and dorsoventral (D-V)
axes (allowing regionally determined functional heterogene-
ity) and subsequently terminal differentiation into diverse
postmitotic neuronal subtypes [2]. Such insights from devel-
opmental neurobiology provide a conceptual framework for
the directed differentiation of hPSCs and allow experimental
interrogation of the molecular “logic” of neuronal subtype
diversification [4]. Taken together with the understanding
that region, and/or subtype, specific degeneration of neurons
underpin the majority of neurodegenerative diseases, these
facts provide a compelling rationale to predictably manip-
ulate the cell fate of hPSCs in order to generate clinically
relevant populations of region specific neurons and glia for
further study [5].
2. Neural Induction
The first mechanistic insights into neural induction originate
from seminal experiments by Spemann and Mangold in the
early part of the twentieth century. In these studies, dorsal
mesodermwas transplanted into the ventral embryo and gen-
erated a secondary host-derived neural tube. The graft itself
was found to contribute to secondary mesodermal structures
including the notochord, while the neural tissue was host-
derived. The ability of the dorsal blastopore lip to reprogram
surrounding tissues when transplanted ectopically justifies
its designation as “organiser tissue.” Equivalent organiser
regions in other vertebrates were subsequently discovered
by the elegant work of Waddington in the 1930s, including
“Hensen’s node” in birds andmammals (Figure 2(a)). Organ-
iser tissue’s capacity to precipitate ectopic neural induction
interspecies suggests evolutionary conservation of underlying
mechanisms. The notion of inductive signals orchestrating
the process of neural induction has become widely accepted.
Accumulating evidence suggests a spatiotemporal interde-
pendence of several signalling pathways in neural induc-
tion, which somewhat challenges the concept of organiser
tissue. The molecular pathways underlying neural induction
remained elusive until the 1990s, when Xenopus studies first
reported that transient dissociation of gastrula-stage animal
caps into single cells resulted in neural fate acquisition and
that misexpression of a dominant-negative Activin receptor,
since being discovered to inhibit multiple transforming
growth factor (TGF𝛽-) related factors, ectopically generated
neural tissue at the expense of mesoderm specification.These
studies suggest that neural induction may occur through a
“de-repression” strategy (i.e., the removal of an inhibitory
signal). Figure 3 depicts the relevant pathways in this process.
2.1.TheRole of TGF-𝛽 Signalling SuperfamilyMembers inNeu-
ral Induction. Themolecular machinery of TGF-𝛽 signalling
is relatively well understood: ligand binding causes receptor
dimerization and initiates a signal transduction pathway and
activates a family of cytoplasmic proteins, the Smads, by
phosphorylation. Eight Smad proteins are encoded in the
human genome, although only five of these (Smad 1, Smad
2, Smad 3, Smad 5, and Smad 8) act as substrates for the TGF
receptor family; these are commonly referred to as “receptor-
regulated Smads,” or just “RSmads.” Broadly, the TGF-𝛽
signalling superfamily encompasses both the Activin/Nodal
and bone morphogenetic protein (BMP) signalling pathways
[6]. The substrates for BMP signalling are Smads 1, 5, and
8, while the Activin/Nodal receptors activate Smads 2 and
3. Co-Smad (Smad 4) functions as a common partner for
all RSmads, whereas Smad 6 and Smad 7 are inhibitory.
Smad/Smad 4 complexes translocate to the nucleus and
activate gene expression.
2.1.1. BMPAntagonism. In the early 1990sNoggin, Follistatin,
and Chordin were identified as genes encoding proteins
with neuralizing activity that were expressed in organiser
tissue. These proteins are inhibitors of BMP signalling, with
a particular bias towards antagonising BMP4, an inhibitor
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Figure 3:Molecular pathways in neural induction. (a)The epiblast (depicted in pink) expresses Nodal.The epiblast throughNodal stimulates
(pink arrow) the expression of BMP4 (depicted in blue) in the extraembryonic ectoderm (blue cells). The extraembryonic ectoderm, by the
action of BMP4, stimulates (blue arrow) the WNT (depicted in pink) pathway in the epiblast that in turn further activates (pink arrow)
Nodal expression. Thus, there is a positive feedback loop between Nodal, BMP, and WNT. Colour scheme: arrows corresponds to the
related tissue/morphogen. (b) The DVE (depicted in red) expresses Cerberus1 and Lefty (also depicted in red) to inhibit Nodal expression,
therefore downregulating Nodal in its proximity. It also expresses Dickkopf (depicted in red), a protein that inhibits WNT3 signals close
to the DVE. Downregulating Nodal and WNT also inhibits BMP4 expression close to the DVE. Thus, there is a gradient of Nodal, WNT,
and BMP with a high expression rostrally and low expression caudally. FGF8 (pink and blue), expressed both in the epiblast (pink) and
extraembryonic ectoderm (blue), also inhibits BMP4 contributing to the gradient. Colour scheme: arrows corresponds to the secreted
inhibitory molecules/tissue source (DVE). They show the consequence of the negative feedback that creates the morphogen gradients in the
R-C axis. (c)TheDVEmigrates into the AVE and the gradients are thus remodelled with lowNodal,WNT, and BMP expression ventrally and
high dorsally. (d) Due to these gradients the neuroectoderm is formed at the ventral pole of the epiblast. Colour scheme: arrows corresponds
to the secreted inhibitory molecules/tissue source (AVE). They show the consequence of the negative feedback that creates the morphogen
gradients in the D-V axis. All timelines are given for mouse and human embryonic development.
of neural fate. BMP4 is expressed widely at the onset of
gastrulation (Figure 3(a)) but is subsequently downregulated
in the neural plate following the emergence of the organiser
region (Figure 2(b)). Blockade of BMP signalling leads to an
expanded neural plate in whole embryos, while mice with
null mutations in BMP antagonists (such as Noggin and
Chordin) show a significantly reduced brain size [1]. The
wider roles of BMP pathway in embryo development are
comprehensively reviewed elsewhere [7].
These facts, taken together, allow a simple molecular
pathway for neural induction to be considered: the extraem-
bryonic ectoderm produces BMPs to promote epidermal
differentiation, while neural inducing regions (organiser
tissues) antagonize BMPs to permit neural induction (Figures
3(a)–3(d)). This can be achieved by blocking BMP mRNA
at the pregastrula stage by Fibroblast Growth Factor (FGF).
Alternatively, the BMP protein can be antagonised at the gas-
trula stage by aforementioned factors secreted from organiser
regions. Against this background, the “default model” of neu-
ral induction was formulated, hypothesizing that gastrula-
stage ectodermal cells have an autonomous predilection to
differentiate into neural tissue and that this process is inhib-
ited by BMPs. In contrast to this model, subsequent studies
have demonstrated that organiser tissue/BMP antagonism
can be dispensable for neural induction, suggesting that addi-
tional mechanisms/signalling pathways merit consideration
in this review, given their potential significance in informing
strategies for neural conversion of hPSCs [1, 8, 9].
2.1.2. Activin/Nodal Antagonism. A significant majority of
studies have focused on the role of BMP inhibition in
neural induction during vertebrate development. However,
the importance of other members of the TGF-𝛽 superfamily,
including Nodal, is also well established [10]. Nodal acts as
an inhibitor of neural induction [11], while Nodal knockout
embryos show increased neuroectoderm specification [12]. A
role forNodal inhibition in neural induction frommouse and
human embryonic stem cells (ESCs) is well established, both
alone [13–15] and combinatorially with BMP antagonism
[16]. Nodal is expressed throughout the epiblast (Figure 3(a))
and inhibitors of this pathway have been identified in the
DVE/AVE [17], which play crucial regulatory roles both in
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Figure 4: Neural patterning. (a) Rostrocaudal gradients of Nodal, BMP4, RA (retinoic acid), and FGF8 important in rostrocaudal patterning.
(b) The interplay between different factors encoding forebrain (PAX6 and OTX2), midbrain (PAX6, OTX2, and EN1/PAX2), and hindbrain
(EN1/PAX2, GBX2, and FGF8). The forebrain-midbrain barrier is defined by the mutually exclusive expression of PAX6 (forebrain) and
EN1/PAX2 (midbrain), while the midbrain-hindbrain boundary by OTX2 (midbrain) and GBX2 (hindbrain). OTX2 and GBX2 are regulated
by FGF8 expression. (c) Dorsoventral patterning with dorsal gradients for BMP4 and WNT and with a ventral gradient of SHH (Sonic
hedgehog). (d) Transverse section through the neural tube depicting various neurons specified by the gradient of SHH from the floor plate
and the BMP4 and WNT from the roof plate: V0–3: interneurons and MN: motor neurons.
neural induction and in repositioning morphogen gradients
between the R-C and D-V axes (Figures 3(b) and 3(c)).
Against this background, we and others have utilised Nodal
antagonism alone to achieve neural specification from hPSCs
in suspension culture [14–16, 18], although the most widely
adopted approach to neural conversion fromhPSCs is termed
dual-Smad inhibition and utilises both Nodal and BMP4
antagonists in combination [16].
2.2. Other Factors Implicated in Neural Induction
2.2.1. Fibroblast Growth Factors (FGFs). FGFs are a diverse
collection of secreted diffusible glycoproteins that act by
binding with differential affinity to four classes of extracellu-
lar receptor (FGFR 1–4). The precise role of FGF signalling
in neural induction remains controversial, but studies col-
lectively suggest an early function to promote competence
for neural conversion and later functions in transcriptional
antagonism of BMP. Another important member of the
FGF family, FGF8, is expressed in the mouse embryo in
the extraembryonic ectoderm and the epiblast before and
during gastrulation (Figures 3(b) and 3(c)). FGF8 activates
calcineurin, which dephosphorylates Smad 1/5, the main
components of the BMP4 pathway [19]. Thus, FGF8 can
inhibit BMP4 signalling leading to neural induction. This
finding further supports the complexity of neural induction
and somewhat challenges the previous “default” model.
Human PSC biology has also contributed to understand-
ing the relevance of FGF in neural induction, with some
studies demonstrating that FGF withdrawal or antagonism
(together with Nodal and BMP4 antagonism) facilitates
neural conversion [20–22], and others suggesting that FGF
has neural inducing capacity [23–26]. These seemingly con-
tradictory findings can be at least partially reconciled through
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recognition that different culture conditions were employed
in each of these studies (e.g., monolayer versus suspension
culture; different programmes of coadministered extrinsic
signals), which may alter the influence of FGF on neural
induction in a context-dependent fashion.
2.2.2. WNT Signalling. WNTs are secreted glycoproteins
responsible for establishment of the dorsoventral axis of the
embryo, a direct consequence of which is the acquisition of
neural identity. Administration of mRNA encoding WNTs
(or their effectors) into the animal hemisphere of one-cell
embryos by injection generates ectopic neural tissue. WNT
signalling is itself activated by BMP4 and implicated in a
Nodal positive feedback loop [27] (Figure 3(a)). The AVE
secretes Dickkopf, a WNT pathway antagonist contributing
initially to the R-C, and later the D-V, Nodal gradient
(Figures 3(b) and 3(c)). However, WNT3 activation does
not impair neural induction in mouse embryos [28], mESCs
[29], and hiPSCs [30]. An extra layer of complexity is added
by the different ways in which WNT can act throughout
development, the canonical 𝛽-catenin pathway (to promote
proliferation), or the noncanonical JNK pathway (to promote
neuronal differentiation) in an FGF2-dependentmanner [31].
These findings collectively suggest that neuroectoderm
specification is likelymore complex than the “default” (BMP4
inhibition) or “organiser” (combined BMP4, WNT3, and
Nodal inhibition) models might suggest. The effects of each
relevant signalling pathway are temporally regulated and
determined by developmental context, justifying their sys-
tematic investigation (both individually and combinatorially)
in the neural conversion of hPSCs [26].
3. Neural Patterning: An Overview
Once specified, the neuroectoderm is subsequently regional-
ized along the R-C axis of the embryonic body (Figures 2(c)
and 4(a)). Organiser regions can be divided into those that
are involved in generating rostral versus caudal structures
in the neuraxis [32]. More specifically, following gastrulation
the head organiser tissue lies under the prechordal neural
plate (anterior neurectoderm), whereas tail organiser tissue
becomes notochord and somites and lies beneath the epi-
chordal neural plate (posterior neurectoderm). Interestingly,
there is evidence that during neural induction in mESCs,
WNTandFGF signalling promote neuromesodermal precur-
sors, a population of cells that gives rise to spinal cord neurons
and paraxial mesoderm [29]. Signals that inhibit BMPs (e.g.,
Noggin) and WNTs (e.g., Dickkopf) stimulate production
of the prechordal plate, insights which have again guided
ontogeny recapitulating hPSC differentiation protocols [33].
The precise timing and mechanisms of neuraxial pat-
terning remain unresolved. A popular model is that neural
induction initially specifies rostral precursors, upon which
caudalising signals subsequently respecify positional identity
in a progressive and stereotyped manner to establish sub-
divisions of the posterior neuraxis. Some of the signalling
pathways implicated in neural induction also appear to play
key roles in early R-C and D-V patterning at later stages [10];
they establish a matrix of positional cues (Figures 4(a) and
4(c)), which in turn influence precursor cell fate specification
through graded concentrations of morphogenetic signals.
In broad terms, the anterior neuroectoderm generates the
forebrain, and the posterior neuroectoderm gives rise to the
midbrain, hindbrain, and spinal cord [32].TheD-V signalling
pathways have more pertinent roles in generating neural
cell-type diversity within each of the aforementioned R-C
subdivisions (Figure 4(c)). It is noteworthy that othermecha-
nisms, such as local signals between developing neurons, also
contribute to the full ensemble of neuronal subtypes. Figure 4
summarizes some of the relevant concepts here, which are
explained in further detail below.
3.1. Early Patterning in the R-C Axis. Evidence from animal
studies suggests that spatially and functionally distinct cell
populations organise development of head and trunk struc-
tures [32]. The head organiser tissue is located in the AVE
and the trunk organiser in the node and anterior primitive
streak (Figure 2(a)). A wealth of evidence implicates BMP
antagonism in forebrain development (Figure 4(a)). Indeed,
neural conversion strategies utilising BMP antagonism in
hPSCs generally report forebrain precursor specification [16,
23, 34, 35].
Studies using a range of approaches have shown that AVE
is necessary for normal forebrain development with Nodal
signalling being critical in this process [1]. Collectively, these
studies suggest that partial reduction of Nodal signalling
primarily affects specification of the prechordal mesendo-
derm, which is necessary for antagonising caudalising signals
and thus perturbs forebrain development. Therefore, Nodal
signalling is necessary for proper R-C patterning of the
neuroectoderm (Figure 4(a)). Smad 2 and Smad 3 are requi-
site intracellular effectors of Nodal signals. Previous reports
implicate Smad 2/3 in neural development; in mice, for
example, Smad 2+/− and Smad 3−/−mutant embryos exhibit a
miniaturized head-like structure [36]. In zebrafish, injection
of mRNAs encoding dominant-negative Smad 2/3 mutants
also results in a smaller head [37]. However, the precise
roles of Smad 2/3 in neural induction and neuroectodermal
patterning remain incompletely understood. Against this
background and consistent with these findings, we and others
have demonstrated that small molecule inhibition of Smad
2/3 imposes caudal regional identity on hPSC-derived neural
precursors [15, 26].
A FGF signalling gradient operates along the R-C axis to
induce the expression of paralogous Hox genes in the neural
tube. Hox genes located at one end of the cluster (3󸀠 end) are
expressed more rostrally in response to low levels of FGF;
conversely genes at the opposite end (5󸀠 end) are expressed
caudally in response to high levels of FGF (Figure 4(a)).
Different Hox genes are consequently expressed at brachial
(Hox4–Hox8), thoracic (Hox8-Hox9), and lumbar (Hox10–
Hox13) levels of the neural tube [38]. The mechanisms by
which a Hox-based transcriptional network choreographs
these processes are now being systematically resolved [39].
These graded FGF signals regulate the primary Hox gene
expression pattern before further superimposed cues refine
subset-specific Hox expression. Rostrally, retinoic acid (RA)
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regulates Hox expression at cervical/brachial levels, in part by
antagonising the FGF gradient (Figure 4(a)). More caudally,
Gdf11 (also a member of the Tgf-𝛽 superfamily) plays an
important role in Hox8–Hox10 gene expression at thoracic
and lumbar neural tube regions [40].
3.2. Patterning in the D-V Axis. The D-V arrangement of
neuraxial anatomy is closely correlated to functional organ-
isation. This anatomical polarity is clearly evident in the
spinal cord where motor neurons reside in the ventral horns
and sensory neurons are positioned in dorsal root ganglia.
In the rostral neuraxis, structures such as the basal ganglia
(including the substantia nigra) are ventrally located, while
the cerebral cortex is dorsally positioned. R-C and D-V
patterning is carefully integrated in a highly stereotyped
manner. Broadly, ventral regional specification requires acti-
vation of both the Nodal and Sonic hedgehog pathways with
antagonism of BMP signalling. Over and beyond its role
in R-C patterning, RA is required for intermediate zone
specification within the D-V axis. Likewise, FGF also plays
important roles in ventral domain specification. The major
contributors to D-V axis formation are BMPs and WNTs
dorsally, and Sonic hedgehog ventrally [41]. Distinct neuronal
subtypes are generated through interaction of opposing
D-V morphogenetic gradients, which form a matrix of
“coordinates” that combinatorially encode discrete precursor
domains in a stereotyped D-V array [2, 3]. In the neural tube,
this developmental strategy underlies motor neurogenesis
and ventral interneurogenesis (Figure 4(d)). Ventral neural
patterning results from morphogens originating from the
floor plate and the notochord. In the early 1990s, different
labs cloned vertebrate homologues of the Drosophila gene
hedgehog, which encode secreted signalling proteins. Sonic
hedgehog (SHH) transpired as the ventrally secreted mor-
phogen conferring D-V neural tube polarity (Figure 4(c)).
It is now well established through a variety of gain- and
loss-of-function studies in different species that SHH plays
crucial and indispensible roles in specifying ventral cell types
throughout the neuroectoderm [41]. SHH is first expressed
in the notochord and later the floor plate, likely secondary to
auto induction (Figure 4(d)). Its function is concentration-
dependent and its major effector mechanism is repression of
GLI3 transcription factor. Spinal motor neuron generation,
for example, depends on two temporally distinct phases
of SHH signalling: an early period where it ventralizes
neural plate precursors and a late period where it promotes
differentiation of these precursors into motor neurons, at
which point there is a concentration-dependent specification
of ventral precursors into motor neurons or interneurons
(Figure 4(d)).
How is positional identity imposed on precursor cells?
Several studies have implicated a group of factors, pre-
dominantly the homeodomain (HD) and basic helix-loop-
helix (bHLH) transcription factors, as crucial regulators here.
These are expressed in strictly organised arrays along the D-
V axis of the neural tube. Individual proteins are designated
as classes I or II by their response to SHH signalling.
Class I proteins are repressed by SHH, thus defining their
ventral limit of expression, while class II protein expression
is induced by SHH and defines dorsal expression boundaries.
Specifically in the context of spinal cord development, such
cross-repressive interactions allow the establishment of five
distinct ventral precursor domains, which in turn permit the
specification of distinct neuronal subtypes. Gain- and loss-
of-function experiments have further supported this putative
mechanism across different species, where ectopic expression
of HD proteins predictably changed the regional allocation of
individual neuronal subtypes within the neural tube [38, 42].
A similar cross-repressive interaction between protein classes
I and II also underlies the developmental “logic” of ventral
spinal neurogenesis. The most ventral aspects of neural
patterning (i.e., floor plate) requireNodal signalling, and FGF
has also been broadly implicated in ventral patterning within
the neuraxis [41].
SHH signalling does not appear to contribute to pattern-
ing in the dorsal neural tube. However, BMPs have similar
and complementary roles in dorsal patterning of the neural
tube and telencephalon (Figure 4(c)). These serve as the
primary dorsal morphogenetic cues by establishing a high
to low concentration from dorsal to ventral positions. In a
similar fashion to SHH in the ventral neural tube, this BMP
gradient enables distinct precursor domains to be defined,
thus permitting the generation of diverse dorsal neuronal
subtypes [43].
4. Directed Differentiation of hPSCs
These aforementioned developmental studies provide a con-
ceptual framework to rationalise both neural induction
strategies and bespoke programmes of morphogenetic cues
for the directed differentiation of hPSCs to clinically relevant
and region specific neurons (summarized in Figure 5 and
Table 1).
4.1. Forebrain. “Default” neural conversion from hPSCs to
forebrain neuronal subtypes has been demonstrated in a
variety of systems including chemically defined suspension
culture, not requiring extrinsic signals, as well as in an
adherent culture method [16, 44, 45]. These studies began in
2007 with the discovery that a selective Rho-associated kinase
(ROCK) inhibitor permits survival of dissociated hPSCs,
thus allowing systematic manipulations to cell fate after
dissociation [44]. A year later, the same lab again employed
serum-free embryoid body-like (SFEB) culture but this time
to recapitulate cell intrinsic and temporally regulated cortical
laminar determination in vitro [45]. These and subsequent
studies have confirmed cortical layer specific expression of
different markers including Reelin in layer 1 (Cajal-Retzius
neurons), TBR1 andCTIP2 in deep layers, and SATB2, BRN2,
and CUX1 in superficial cortical layers [46]. Such default
dorsal telencephalic differentiation strategies tend to give rise
to predominantly glutamatergic, but also some GABAergic,
neurons [47].
Prior to terminal differentiation, if specified dorsal telen-
cephalic precursors are exposed to SHH and/or a WNT
antagonist, they are ventralised to generate subpallial deriva-
tives (i.e., of the lateral and medial ganglionic eminences;
LGE and MGE, respectively). Upon terminal differentiation,
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Table 1
Cell type Study Culture method Programme of developmental cues for neuralconversion and patterning Duration (days)
Cortical precursors Watanabe et al. 2007 [44]
Serum-free
embryoid body-like
(SFEB)
BMP antagonist (BMPRIA-Fc)
Activin/Nodal antagonist (LeftyA)
Wnt antagonist (Dkk1)
35
Cortical neurons Eiraku et al. 2008 [45] SFEB derivative
BMP antagonist (BMPRIA-Fc)
Activin/Nodal antagonist (LeftyA)
Wnt antagonist (Dkk1)
45–60
Cortical neurons Chambers et al. 2009 [16] Monolayer BMP antagonist (NOGGIN)Activin/Nodal antagonist (SB431542) 19
Cortical neurons and
MGE/LGE neurons Li et al. 2009 [47] Suspension
None for cortical (endogenous Wnt)
For MGE and LGE derivatives:
Wnt antagonist (Dkk1)
Sonic hedgehog (SHH)
30–35
Cortical neurons Shi et al. 2012 [46] Monolayer BMP antagonist (NOGGIN)Activin/Nodal antagonist (SB431542) 80–100
Midbrain
dopaminergic neurons Kriks et al. 2011 [50] Monolayer
BMP antagonist (NOGGIN or LDN)
Activin/Nodal antagonist (SB431542)
Sonic hedgehog (SHH and purmorphamine),
Fibroblast Growth Factor 8b (FGF8b),
Wnt agonist (CHIR99021)
80
Midbrain
dopaminergic neurons Kirkeby et al. 2012 [48] Embryoid body
BMP antagonist (NOGGIN)
Activin/Nodal antagonist (SB431542)
Wnt agonist (CT99021)
Sonic hedgehog (SHH-C24II)
35
Midbrain
dopaminergic neurons Jaeger et al. 2011 [52] Monolayer
BMP antagonist (NOGGIN)
Activin/Nodal antagonist (SB431542)
FGF/ERK antagonist (PD0325901)
Fibroblast Growth Factor 8b (FGF8b),
Sonic hedgehog (SHH)
30–35
Cerebellar neurons Erceg et al. 2012 [59] Embryoid body
Fibroblast Growth Factors (FGF8, FGF4, and
FGF2)
Retinoic acid (RA)
Wnt agonists (Wnt1, Wnt3a)
BMPs (BMP4, BMP6, BMP7, and GDF7)
Sonic hedgehog (SHH)
35
Cerebellar neurons Muguruma et al. 2015 [57] SFEBq
Activin/Nodal antagonist (SB431542)
Fibroblast Growth Factors (FGF2, FGF19)
Insulin
Stromal cell-derived factor 1 (SDF-1)
(co-culture with mouse granule cells to
generate Purkinje cells)
35–135
Cerebellar neurons Wang et al. 2015 [58] Embryoid body
Fibroblast growth factor (FGF2)
Insulin
Sonic hedgehog antagonist (cyclopamine)
(coculture with rat organotypic cerebellar slice
to generate Purkinje cells)
20–65
Spinal cord motor
neurons Li et al. 2005 [63] Monolayer
Retinoic acid (RA)
Sonic hedgehog (SHH)
Fibroblast Growth Factor (FGF2)
21–35
Spinal cord motor
neurons Patani et al. 2011 [18] Suspension
Activin/Nodal antagonist (SB431542)
Sonic hedgehog (purmorphamine)
Fibroblast Growth Factor (FGF2)
21–35
Spinal cord motor
neurons Calder et al. 2015 [67] Monolayer
Activin/Nodal antagonist (SB431542)
BMP antagonist (LDN193189)
Retinoic acid (RA)
35–40
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hiPSC/epiblast equivalents
Neural induction
BMP inhibition/
dual-Smad inhibition
(BMP4, NODAL inhibition)
Neuroectoderm
Directed
differentiation
Adherent culture
(monolayer/coculture)
or
suspension culture
Forebrain: no external
Midbrain:
Hindbrain:
Spinal cord:
WNT, FGF, and RA
WNT, FGF, and RA
Ventral Dorsal
Rostral
Caudal
WNTRA
SHH
FGF8
WNT (Chir), and FGF8
morphogens
Figure 5: Methods for directed differentiation: hPSCs can be directed to undergo neural conversion by applying developmental principles
of inhibiting BMP4 and/or Nodal. From neuroectoderm, differentiation of different neuraxial regions can be achieved by recapitulating
developmental morphogenetic instruction: forebrain (default), midbrain (WNT, FGF8 activation), hindbrain (WNT, FGF8, and others, RA),
and spinal cord (WNT, FGF8, and others, RA). These gradients are shown on the right of the figure for the rostrocaudal axis. Another
important morphogenetic cue used in directed differentiation is SHH for its ventralising effect within the D-V axis. All timelines are given
for mouse and human embryonic development.
these ventralised telencephalic cultures give rise to GABAer-
gic projection neurons and interneurons. Clinically relevant
cell types originate from the LGE (e.g., medium spiny projec-
tion GABAergic neurons, which are relevant to Huntington’s
disease and dystonia) and the MGE (e.g., basal forebrain
cholinergic neurons relevant to Alzheimer’s disease). Further
sophistication can be added to the aforementioned directed
differentiation strategies by carefully regulating SHH and
WNT pathways (which orchestrate dorsoventral positional
identity in this context). For example, a low concentration of
SHH alone permits the specification of both LGE and MGE
derivatives, whereas if a WNT antagonist is added to SHH,
the more ventral MGE (i.e., NKX2.1 expressing) neurons are
preferentially specified at the expense of LGE (i.e., GSX2,
DLX, MEIS2, and ISLET1 expressing) neurons. Some elegant
and ontogeny recapitulating strategies have been defined for
the generation of authentic DARPP32 expressing medium
spiny projection neurons [33, 47].
4.2. Midbrain. Differentiating hPSCs into midbrain
dopaminergic neurons has maintained great enthusiasm
likely owing to their potential to understand and treat
Parkinson’s disease. Although dopaminergic neurons exist
throughout the nervous system, there is a region-specific
functional heterogeneity that has been experimentally
demonstrated by performing anisotopic implantation
experiments [48]. Midbrain dopaminergic neurons are
developmentally partitioned to three distinct nuclei: (i) the
substantia nigra pars compacta (A9 group), which is primar-
ily affected in Parkinson’s disease, (ii) the ventral tegmental
area (A10 group), and (iii) the retrorubral field (A8 group).
Noting that hPSC-derived neural precursors have a default
rostral (forebrain) and dorsal (cortical) identity, morphogen-
guided positional respecification, or patterning, to the
ventral mesencephalon is necessary for the differentiation
of authentic midbrain dopaminergic neurons. Feeder-free
and feeder-dependent differentiation approaches have both
been employed to generate midbrain dopaminergic neurons
from hPSCs. Feeder-dependent differentiation strategies
have utilisedmouse stromal cell lines (e.g., PA6), which, even
though relatively easy to establish, carry the main disadvan-
tage of being chemically undefined and animal-derived. From
developmental in vivo studies, we are guided by the insight
that FGF8 signalling leads to a cross-repressive interaction
between Otx2 and Gbx2, defining the midbrain-hindbrain
boundary (MHB; Figure 4(b)) and imparting rostrocaudal
positional identity to precursors of the MHB [49]. Otx2
and Gbx2 control patterning in this region by regulating the
expression of two morphogenetic cues, WNT1 in midbrain
and FGF8 in the hindbrain. Furthermore, in combination
with Otx2 expression, cross-repressive mechanisms between
Pax6 and En1/Pax2 define boundaries of regional fate
allocation to either forebrain or midbrain (Figure 4(b)).
Against this background, initial approaches to midbrain
differentiation were based on FGF8 for R-C patterning to
the region of the midbrain, and SHH for ventralization into
dopaminergic neurons, although the yields were low (approx.
30%) using such strategies. Furthermore, subsequent studies
have raised the possibility that PA6 and SHH/FGF8-based
approaches alone are not sufficient to generate authentic
midbrain dopaminergic neurons [50, 51]. The field then
underwent a period of reevaluation where protocols that
recapitulated ventral mesencephalic development with more
fidelity and precision were developed. During this time,
earlier protocols were systematically refined and superseded
by studies using WNT agonists [48, 50], most notably
from the Studer Lab who established an efficient midbrain
floor plate differentiation strategy through which dopamin-
ergic neurons were efficiently specified. Crucially, this study
demonstrated functional engraftment and recovery in mice,
rats, and nonhuman primates with Parkinson’s disease [50].
Contemporaneous studies showed that by using canonical
WNT agonists at different concentrations and for defined
durations, the generation of diverse regionally specified
progenitors from fore- to hindbrain is possible. Interestingly,
the generated midbrain dopaminergic neurons, but not
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their telencephalic counterparts, could reverse structural and
functional deficits in animal models of Parkinson’s disease.
This subtype specificity highlights the unparalleled potential
of directed differentiation of hPSCs in regenerative medicine
[48]. A further notable study in this arena used transient
blockade of FGF signalling to refine midbrain positional
identity and yield authentic dopaminergic neurons with
high efficiency [52]. Although it can be argued that these
later studies yield more authentic midbrain dopaminergic
neurons because they utilised developmentally rationalised
cues, it should be noted that the GSK3𝛽 inhibitors such
as CHIR99021 used here for WNT pathway activation do
have off target effects (i.e., they regulate pathways other than
WNT) [53]. Additionally it is noteworthy that more specific
WNT pathway activators (e.g., WNT3a) do not reproducibly
generate midbrain dopaminergic neurons with the same
efficiency as the GSK3𝛽 inhibitor CHIR99021 [50, 54]. In
future studies, the absolute requirement forGSK3𝛽 inhibition
and the identification of additional key regulatory pathways
would be of great importance to establish.
4.3. Hindbrain and Cerebellum. Broadly, evolutionary path-
ways appear to be more conserved in caudal (primitive)
regions of the CNS such as the hindbrain. The hindbrain
can be divided into rostral and caudal portions, which are
separated by rhombomere 4 (r4). Neurons derived from
rostral regions project to and innervate myriad brain regions,
whereas the caudal portion, located in the myelencephalon,
gives rise mainly to descending spinal projections. The
brain innervating central serotonergic neurons, originating
from r2-3 of the rostral raphe, contribute to higher order
brain functions and are implicated in a range of psychi-
atric disorders. By using EGF and FGF2 in the mainte-
nance media, so-called “long-term self-renewing rosette-
type” hPSC-derived neural precursors can be expanded
which exhibit a ventral anterior hindbrain-like expression
profile after prolonged culture [55]. These precursors prefer-
entially generated GABAergic neurons, some of which were
serotonergic neurons. This finding likely reflects positional
respecification of the default forebrain identity secondary
to protracted culture in FGF2, which is known to have
caudalising properties. Very recently, a protocol for directed
differentiation of hPSCs to functionally validated hindbrain
serotonergic neurons through activation of the WNT and
SHH pathways was reported [56].
There are few reports of cerebellar differentiation with
demonstration of electrophysiologically mature and func-
tional Purkinje- and granule-cell specification [57, 58].
A recent study generated MATH1-positive cerebellar-like
granule cells from iPSCs using a complex programme of
sequentially administeredmorphogens, including FGF8, RA,
FGF4, FGF2, WNT1a, WNT3a, BMP4, GDF7, BMP7, BMP6,
SHH, BDNF, Jagged1, and NT3 [59]. More recently an
ontogeny recapitulating strategy for cerebellar neurogenesis
achieved efficient directed differentiation of hPSCs using
three morphogens only [57]. Here, hPSC-derived embryoid
bodies were first positionally specified to the midbrain-
hindbrain boundary and subsequently directed to cerebellar
plate neuroepithelium (CPNE). CPNE in turn gave rise
to functionally mature Purkinje- and granule cells, DCN-
neurons, and various interneurons in specific coculture set-
tings by sequentially administering FGF2, FGF19, and SDF1.
A contemporaneous study used insulin, FGF2, and an antag-
onist of SHH signalling (cyclopamine), again necessitating
coculture with rat cerebellar slices to reinforce the validity
of this approach for directed differentiation to cerebellar
neurons [58]. Both of these recent studies relied to some
degree on coculture with isotopic organotypic slices/rodent
cerebellar derivatives. Future studies in this area should focus
on overcoming reliance on coculture with rodent or human
cerebellar slice cultures by identifying the requisite extrinsic
signals for specifying cerebellar derivatives at each stage of
their lineage restriction.
4.4. Spinal Cord. The generation of functional spinal cord
derivatives, includingmotor neurons, has been achieved from
hPSCs through a variety of approaches using insights from
developmental biology [15, 60–62].These strategies employed
either simultaneous or sequential administration of caudal-
ising (e.g., RA) and ventralising (e.g., SHH) morphogens
prior to terminal differentiation. These studies confirmed
the expression of specific motor neuron fate determin-
ing factors including HB9, specific enzymes/transporters
including choline acetyltransferase (ChAT) and the vesicular
acetylcholine neurotransmitter transporter (vAChT), and
also coculture with myotubes to demonstrate the formation
of physiologically relevant neuromuscular junctions [18, 60,
63]. Electrophysiological studies confirm that hPSC-derived
motor neurons acquire appropriate functional properties
[60]. Motor neuron precursors have importantly been shown
to survive and integrate in rodent embryonic spinal cord
[64, 65] and to project axons forming physiological synapses.
Treating cultures with RA typically results in a cervical
or brachial positional identity [18, 65]. More caudal (lumbar)
motor neuron fates can also be achieved in the absence
of RA signalling, likely in response to FGF2; indeed we
have reported a retinoid independent strategy for motor
neurogenesis from hPSCs that yields a lumbar spinal subtype
identity and favours medial motor columnar specification
[18]. This retinoid-mediated diversification of motor neuron
subtypes was further supported by a parallel study using
mouse embryonic stem cells [65]. A recent study employed
combined retinoic acid andWNTagonism to generate cranial
motor neurons from hPSCs [66]. Yet another subsequent
study reported the derivation of motor neurons under RA
treated but SHH free conditions, uncovering important
insights into humanmotor neurodevelopmental biology [67].
4.5. Neural Crest. Neural crest cells are highly migratory
and give rise to myriad differentiated cell types including
(i) sensory and autonomic neurons and Schwann cells, (ii)
chromaffin cells in the adrenal medulla, (iii) melanocytes,
and (iv) cranial skeletal and connective tissue components.
The fate of the neural crest cells is largely determined by
where they migrate to/settle. From an hPSC perspective,
striking phenotypic consequences have been demonstrated
based on plating density, and this provides a strategy to
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generate neural crest derivatives. A high plating density
favours PAX6 expressing central nervous system precursors
while low plating density specified neural crest-like differen-
tiation [16]. Using variations of this approach, stage-specific
isolation/differentiation of hPSC-derived neural crest cells
has been achieved using a combination of in vitro expansion,
directed differentiation via extrinsic signals and cell sorting.
For example, serum-free conditionswith subsequent bespoke
programmes of extrinsic cues can permit specification of
Schwann cells, autonomic or sensory neurons, while serum
based approaches tend to favour mesenchymal derivatives
including adipocytes, osteocytes, chondrocytes, and smooth
muscle. Functional validation has been demonstrated by
transplantation of hPSC-derived neural crest cells into a chick
embryo, where they exhibit preserved neural crest identity in
the context of survival, migration, and differentiation [68].
5. Concluding Remarks
Theunrivalled complexity of themammalian central nervous
system is enabled by a series of progressive and sequential
events during embryogenesis. The degree of interconnect-
edness within the central neuraxis is somewhat surpris-
ing given its impressively precise organisation into discrete
regions. Evolutionary conservation of developmental pro-
cesses underlying the organisation of such discrete neural
regions becomes increasingly less applicable to more rostral
(i.e., evolutionarily “newer”) components, like the forebrain.
The hPSC platform is emerging as an important reductionist
in vitro system to interrogate aspects of human development,
which have remained experimentally inaccessible until now.
Current approaches towards such directed differentiation
of hPSCs often fail to capture the dynamic and overlapping
nature of neurodevelopmental processes. For instance, neural
induction and patterning are often conceptualised as mecha-
nistically distinct processes. However, a bias towards different
regional fates will likely be determined by the neural con-
version paradigm employed. Similarly current differentiation
strategies do not yet fully acknowledge or exploit the ability to
influence cell (subtype) fate decisions postmitotically, which
has been reported [69–71]. As such, the field’s approach to
directed differentiation to individual cellular subtypes could
potentially benefit from being more closely aligned to each
respective stage of neurodevelopment, leading to bespoke
conditions for each stage of lineage restriction (i.e., neural
conversion, patterning, and terminal differentiation).
Developmental principles are a crucial resource for defin-
ing ontogeny recapitulating directed differentiation protocols
for hPSCs (Figure 5). In addition to the wealth of knowl-
edge that already exists from rodent developmental biology,
there is an increasing number of publicly available human
brain region-specific and transcriptome-wide datasets from
studies using a diverse range of tissue from fetal through
to adult stages [72–74]. In addition to highlighting the
maturational status of hPSC-derived neurons [75], such
developmental/stage-specific data sets could now serve as
a gold standard for validating directed differentiation pro-
tocols to region-specific cell types. Indeed these datasets
should eventually contribute to experimental design when
a relatively unexplored region of the nervous system is being
investigated using hPSCs. The utilisation of human brain-
derived data bypasses potential issues of evolutionary diver-
gence betweenmouse andman, especially in themore rostral
(evolutionarily newer) regions of the neuraxis. Coupling
insights gained from these invaluable resources together with
high throughput platforms for protocol discovery would be
a future avenue for improving the robustness of current
directed differentiation strategies [66].
Finally, the hPSC field stands to benefit from defin-
ing multiple directed differentiation protocols that employ
closely aligned methods for neural conversion and similar
protocol durations. This may then permit more meaningful
comparison between region-specific neurons, without the
potentially confounding issue of differential cellular matu-
ration. Indeed such an approach was recently utilised to
show region-specific phenotypes using iPSCs derived from
patients with Alzheimer’s disease and motor neuron disease
[76]. Taken together, such standardizations in directed dif-
ferentiation of hPSCs may help to drive the identification
of robust strategies to specify enriched populations of all
clinically relevant region-specific subpopulations of human
neurons for further study.
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